 |
The Journal of the Japanese Society for Clinical Microbiology |
Biblioraphy Information
| ArticleTitle |
Survey report on the severe acute respiratory syndrome coronavirus 2 testing systems in Ishikawa Prefecture |
| Language |
J |
| AuthorList |
Yukie Katayama1), Akiko Niikawa2), Akiko Maekawa3), Yoshitsugu Iinuma4) |
| Affiliation |
1) Department of Clinical Laboratory, Asanogawa General Hospital
2) Department of Clinical Laboratory, Ishikawa Prefectural Hospital of Mental Health
3) Department of Clinical Laboratory, Kanazawa University Hospital
4) Department of Infectious Diseases, Kanazawa Medical University |
| Publication |
J.J.C.M.: 33 (1), 72-77, 2022 |
| Received |
July 13, 2022 |
| Accepted |
September 26, 2022 |
| Abstract |
Although testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing is being conducted in many hospitals, clinics, and clinical laboratory testing centers, there are only few reports on the testing systems and equipment used. In this study, we conducted a questionnaire survey of the testing systems and equipment used for SARS-CoV-2 testing in Ishikawa Prefecture. Among the 74 facilities that are members of the Japan Society of Laboratory Medicine and Hygiene Technologists in Ishikawa Prefecture, 46 facilities responded to the questionnaire survey of this study. In total, 42 facilities (91.3%) tested for novel coronaviruses at their own facilities, 31 performed for nucleic acid detection tests, 27 performed qualitative antigen tests (immunochromatography), and 3 performed quantitative antigen tests (chemiluminescence immunoassay). ID NOW and Smart Gene, which are widely used in Ishikawa Prefecture, were mainly used during office hours in facilities with less than 300 beds. In the facilities with more than 300 beds, these instruments were used as alternatives during office hours and used outside of office hours when no technologists dedicated for SARS-CoV-2 testing were available. |
| Keywords |
SARS-CoV-2 |
|
